CAS No.:10141-00-1

TOXICITY DATA with REFERENCE：

1.		cyt-ham:ovr 1 mg/L		CRNGDP    Carcinogenesis. 3 (1982),1331.
2.		sce-ham:ovr 1 mg/L		CRNGDP    Carcinogenesis. 3 (1982),1331.

Consensus Reports：

IARC Cancer Review: Group 3 IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Chromium and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

SAFETY PROFILE：

Mutation data reported. Questionable carcinogen. When heated to decomposition it emits toxic fumes of K₂O. See also CHROMIUM COMPOUNDS and SULFATES.
Risk Statements 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements 26
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RTECS GB6845000
 

Standards and Recommendations：

OSHA PEL: TWA 0.5 mg(Cr)/m³
ACGIH TLV: TWA 0.5 mg(Cr)/m³; Not Classifiable as a Carcinogen

Analytical Methods：